It gives me immense pleasure to welcome you to PharmDart and to introduce our flagship initiative, IJPHARMDART (International Journal of PharmDart e-ISSN: 3139-1117). Our organization stands at the intersection of innovation, research excellence, and practical industry application, with a commitment to advancing the pharmaceutical and healthcare domains.

 

At PharmDart, we strive to create a dynamic ecosystem that bridges academia, research, and industry. We understand that meaningful progress in healthcare requires not only scientific rigor but also collaboration, transparency, and accessibility. Our platform is designed to support researchers, professionals, and organizations in sharing knowledge, developing solutions, and translating ideas into real-world impact.

 

IJPHARMDART represents our dedication to high-quality scholarly publishing. The journal aims to provide a credible and inclusive platform for researchers, academicians, and industry experts to disseminate their work. We emphasize originality, ethical research practices, and global relevance, ensuring that every publication contributes to the advancement of pharmaceutical sciences and allied fields.

 

To our researchers and authors, we offer a supportive environment that values innovation and critical thinking. To our industry partners, we present opportunities for collaboration, knowledge exchange, and the development of impactful solutions. To our users and clients, we remain committed to delivering reliable, accessible, and valuable scientific content.

 

As we move forward, our vision is to expand PharmDart into a globally recognized hub for pharmaceutical research, education, and industry engagement. We believe in continuous improvement, embracing emerging technologies, and fostering partnerships that drive sustainable growth and innovation.

 

I invite all stakeholders to join us in this journey—contributing knowledge, sharing expertise, and shaping the future of healthcare together.

 

Thank you for your trust and support.

 

Warm regards,

Mrs. Roopali Agrawal 

Director-in-Charge

PharmDart Consulting Pvt. Ltd.

8319119935